Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetic and nongenetic determinants of between-patient variability in the pharmacokinetics of mycophenolic acid.

× No keyword cloud information.

19 in total

1. Inosine 5'-monophosphate dehydrogenase 1 haplotypes and association with mycophenolate mofetil gastrointestinal intolerance in pediatric heart transplant patients.

Authors: Erin L Ohmann; Gilbert J Burckart; Yan Chen; Vera Pravica; Maria M Brooks; Adriana Zeevi; Steven A Webber
Journal: Pediatr Transplant Date: 2010-11

Review 2. Clinical mycophenolic acid monitoring in liver transplant recipients.

Authors: Hao Chen; Bing Chen
Journal: World J Gastroenterol Date: 2014-08-21 Impact factor: 5.742

Review 3. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Authors: Christine E Staatz; Susan E Tett
Journal: Clin Pharmacokinet Date: 2007 Impact factor: 6.447

4. Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients.

Authors: Dirk R Kuypers; Henrik Ekberg; Josep Grinyó; Björn Nashan; Flavio Vincenti; Paul Snell; Richard D Mamelok; Rene M Bouw
Journal: Clin Pharmacokinet Date: 2009 Impact factor: 6.447

Review 5. Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.

Authors: Teun van Gelder; Ron H van Schaik; Dennis A Hesselink
Journal: Nat Rev Nephrol Date: 2014-09-23 Impact factor: 28.314

6. Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus.

Authors: Catherine M T Sherwin; Anna Carmela P Sagcal-Gironella; Tsuyoshi Fukuda; Hermine I Brunner; Alexander A Vinks
Journal: Br J Clin Pharmacol Date: 2012-05 Impact factor: 4.335

7. Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.

Authors: L'aurelle A Johnson; William S Oetting; Saonli Basu; Susie Prausa; Arthur Matas; Pamala A Jacobson
Journal: Eur J Clin Pharmacol Date: 2008-06-21 Impact factor: 2.953

8. Clinical effectiveness of rivastigmine monotherapy and combination therapy in Alzheimer's patients.

Authors: Nirmal Sonali; Manjari Tripathi; Rajesh Sagar; Thirumurthy Velpandian; Vivekanandhan Subbiah
Journal: CNS Neurosci Ther Date: 2012-12-04 Impact factor: 5.243

Review 9. Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.

Authors: J Michael Tredger; Nigel W Brown; Anil Dhawan
Journal: Drugs Date: 2008 Impact factor: 9.546

10. Prediction of Free from Total Mycophenolic Acid Concentrations in Stable Renal Transplant Patients: A Population-Based Approach.

Authors: Helena Colom; Franc Andreu; Teun van Gelder; Dennis A Hesselink; Brenda C M de Winter; Oriol Bestard; Joan Torras; Josep M Cruzado; Josep M Grinyó; Núria Lloberas
Journal: Clin Pharmacokinet Date: 2018-07 Impact factor: 6.447